{"altmetric_id":20107511,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":12},"twitter":{"unique_users_count":10,"unique_users":["iasociety","PY1US","YvesGebhardt","Dr_ClaireThorne","jhourcade","edyleon64","TheRockOfHopeSD","LundiAnne1","jiasociety","NJotwoma"],"posts_count":11},"facebook":{"unique_users_count":1,"unique_users":["296268839696"],"posts_count":1}},"selected_quotes":["#HIV dual therapy with dolutegravir and lamivudine: 48-week trial results from PADDLE published","JIAS is proud to present the first pilot study of #dolutegravir and #lamivudine combination therapy for #HIV.","Very interesting results. Hope further clinical trails are conducted with more patients 4 better appreciation"],"citation":{"altmetric_jid":"4f6fa4d03cf058f610000867","doi":"10.7448\/ias.20.1.21678","first_seen_on":"2017-05-13T12:31:43+00:00","issns":["1758-2652"],"journal":"Journal of the International AIDS Society","last_mentioned_on":1496029766,"links":["http:\/\/www.jiasociety.org\/index.php\/jias\/article\/view\/21678\/html","http:\/\/jiasociety.org\/index.php\/jias\/article\/view\/21678"],"pdf_url":"http:\/\/www.jiasociety.org\/index.php\/jias\/article\/view\/21678\/pdf","pubdate":"2017-10-05T00:00:00+00:00","publisher_subjects":[{"name":"Other Medical And Health Sciences","scheme":"era"}],"title":"Dolutegravir\u2013lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study","type":"article"},"altmetric_score":{"score":7.5,"score_history":{"1y":7.5,"6m":7.5,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7.5},"context_for_score":{"all":{"total_number_of_other_articles":8286032,"mean":6.9859461464656,"rank":1157990,"this_scored_higher_than_pct":85,"this_scored_higher_than":7121957,"rank_type":"exact","sample_size":8286032,"percentile":85},"similar_age_3m":{"total_number_of_other_articles":244264,"mean":12.323503371366,"rank":48627,"this_scored_higher_than_pct":80,"this_scored_higher_than":195464,"rank_type":"exact","sample_size":244264,"percentile":80},"this_journal":{"total_number_of_other_articles":1063,"mean":5.8228455743879,"rank":252,"this_scored_higher_than_pct":76,"this_scored_higher_than":811,"rank_type":"exact","sample_size":1063,"percentile":76},"similar_age_this_journal_3m":{"total_number_of_other_articles":48,"mean":9.1542553191489,"rank":23,"this_scored_higher_than_pct":52,"this_scored_higher_than":25,"rank_type":"exact","sample_size":48,"percentile":52}}},"demographics":{"poster_types":{"member_of_the_public":6,"practitioner":1,"science_communicator":3},"users":{"twitter":{"cohorts":{"Members of the public":6,"Science communicators (journalists, bloggers, editors)":3,"Practitioners (doctors, other healthcare professionals)":1}}},"geo":{"twitter":{"US":2,"GB":1,"AR":1,"SZ":1,"CM":1,"CH":1,"KE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/iasociety\/statuses\/863370884391809028","license":"gnip","citation_ids":[20107511],"posted_on":"2017-05-13T12:30:34+00:00","author":{"name":"Int. AIDS Society","url":"http:\/\/www.iasociety.org","image":"https:\/\/pbs.twimg.com\/profile_images\/875375681999339520\/bEyXTFGo_normal.jpg","description":"IAS is the world's largest independent association of HIV professionals. Together we advocate and drive urgent action to reduce the global impact of HIV.","id_on_source":"iasociety","tweeter_id":"46158711","geo":{"lt":null,"ln":null},"followers":15221},"tweet_id":"863370884391809028"},{"url":"http:\/\/twitter.com\/PY1US\/statuses\/863377996916326401","license":"gnip","rt":["iasociety"],"citation_ids":[20107511],"posted_on":"2017-05-13T12:58:49+00:00","author":{"name":"Protect Yourself 1","url":"http:\/\/protectyourself1.org","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000334688559\/6896251cde6dd998d0d29e9950e55eb2_normal.jpeg","description":"Mission: To increase Awareness, Education and\r\nPrevention of HIV & related diseases by using entertainment, events, virtual reality. Exec. Dir.: Monique Richert","id_on_source":"PY1US","tweeter_id":"228802696","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":233},"tweet_id":"863377996916326401"},{"url":"http:\/\/twitter.com\/YvesGebhardt\/statuses\/863427843333783552","license":"gnip","rt":["iasociety"],"citation_ids":[20107511],"posted_on":"2017-05-13T16:16:54+00:00","author":{"name":"Yves Gebhardt","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","description":"Life is uncertain, let's eat dessert first! - Community Correspondent at #ACTG2017 in #DC June 25-29, 2017 - opinions are my own -","id_on_source":"YvesGebhardt","tweeter_id":"745689613","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":227},"tweet_id":"863427843333783552"},{"url":"http:\/\/twitter.com\/Dr_ClaireThorne\/statuses\/863429281988431872","license":"gnip","rt":["iasociety"],"citation_ids":[20107511],"posted_on":"2017-05-13T16:22:37+00:00","author":{"name":"Claire Thorne","image":"https:\/\/pbs.twimg.com\/profile_images\/514422850317348864\/btAVPs-B_normal.jpeg","description":"Infectious diseases epidemiologist @ucl_slms @UCL_ICH. HIV, viral hepatitis, zika virus, STIs. Main focus on maternal and child health.","id_on_source":"Dr_ClaireThorne","tweeter_id":"2828165101","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":170},"tweet_id":"863429281988431872"},{"url":"http:\/\/twitter.com\/jhourcade\/statuses\/863488175695646720","license":"gnip","rt":["iasociety"],"citation_ids":[20107511],"posted_on":"2017-05-13T20:16:38+00:00","author":{"name":"Javier Hourcade","url":"http:\/\/www.quieroprep.org","image":"https:\/\/pbs.twimg.com\/profile_images\/850405516002168832\/x-9aBjq7_normal.jpg","description":"Presidente de la Junta @gnpplus, Editor @cooresponsalvih, Coordinador @quieroprep, Consultor Independiente y mas.","id_on_source":"jhourcade","tweeter_id":"56914638","geo":{"lt":-34.61315,"ln":-58.37723,"country":"AR"},"followers":1007},"tweet_id":"863488175695646720"},{"url":"http:\/\/twitter.com\/edyleon64\/statuses\/863503471764357121","license":"gnip","citation_ids":[20107511],"posted_on":"2017-05-13T21:17:25+00:00","author":{"name":"Eddie A Leon Juarez","image":"https:\/\/pbs.twimg.com\/profile_images\/621105130398597120\/C212MuRD_normal.jpg","id_on_source":"edyleon64","tweeter_id":"3269326274","geo":{"lt":null,"ln":null},"followers":136},"tweet_id":"863503471764357121"},{"url":"http:\/\/twitter.com\/TheRockOfHopeSD\/statuses\/863672941875257345","license":"gnip","rt":["iasociety"],"citation_ids":[20107511],"posted_on":"2017-05-14T08:30:50+00:00","author":{"name":"The Rock of Hope","url":"http:\/\/www.Therockofhopesd.com","image":"https:\/\/pbs.twimg.com\/profile_images\/717814131047407617\/IlE1RDNH_normal.jpg","description":"Community based organization supporting the needs for the rights of LGBTI individuals in Swaziland.\nWe are situated at FLAS offices in Manzini.","id_on_source":"TheRockOfHopeSD","tweeter_id":"717811512178524162","geo":{"lt":-26.5,"ln":31.5,"country":"SZ"},"followers":173},"tweet_id":"863672941875257345"},{"url":"http:\/\/twitter.com\/LundiAnne1\/statuses\/863814178443853826","license":"gnip","rt":["iasociety"],"citation_ids":[20107511],"posted_on":"2017-05-14T17:52:03+00:00","author":{"name":"Lundi Anne","url":"http:\/\/www.reachoutcameroon.org","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000018853472\/51eec22692e536fa6180d1434faa36f7_normal.jpeg","description":"Public Health Expert working with Reach Out Cameroon. PMTCT, HIV, SRH. \n2015 Africa Youth Awards Winner","id_on_source":"LundiAnne1","tweeter_id":"1080142699","geo":{"lt":4.1527,"ln":9.241,"country":"CM"},"followers":315},"tweet_id":"863814178443853826"},{"url":"http:\/\/twitter.com\/LundiAnne1\/statuses\/863814704736718848","license":"gnip","citation_ids":[20107511],"posted_on":"2017-05-14T17:54:09+00:00","author":{"name":"Lundi Anne","url":"http:\/\/www.reachoutcameroon.org","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000018853472\/51eec22692e536fa6180d1434faa36f7_normal.jpeg","description":"Public Health Expert working with Reach Out Cameroon. PMTCT, HIV, SRH. \n2015 Africa Youth Awards Winner","id_on_source":"LundiAnne1","tweeter_id":"1080142699","geo":{"lt":4.1527,"ln":9.241,"country":"CM"},"followers":315},"tweet_id":"863814704736718848"},{"url":"http:\/\/twitter.com\/jiasociety\/statuses\/867402508263714816","license":"gnip","citation_ids":[20107511],"posted_on":"2017-05-24T15:30:48+00:00","author":{"name":"Journal of the IAS","url":"http:\/\/www.jiasociety.org","image":"https:\/\/pbs.twimg.com\/profile_images\/2881440289\/5f6fdfba979c4b22d32c39e7d2cf6524_normal.png","description":"The Journal of the International AIDS Society is an open access, peer-reviewed journal publishing HIV research with a focus on resource-limited settings","id_on_source":"jiasociety","tweeter_id":"964200672","geo":{"lt":46.16667,"ln":6.16667,"country":"CH"},"followers":929},"tweet_id":"867402508263714816"},{"url":"http:\/\/twitter.com\/NJotwoma\/statuses\/869037943545049088","license":"gnip","rt":["jiasociety"],"citation_ids":[20107511],"posted_on":"2017-05-29T03:49:26+00:00","author":{"name":"Nelson J. Otwoma","image":"https:\/\/pbs.twimg.com\/profile_images\/854674636826718208\/Z5HXFu-B_normal.jpg","description":"Works @NEPHAKKENYA, Member, @HIVTribunalKe Mentor to @SautiSkika1 @Blastcampus Tweets  are mine","id_on_source":"NJotwoma","tweeter_id":"2175288283","geo":{"lt":-1.28333,"ln":36.83333,"country":"KE"},"followers":2519},"tweet_id":"869037943545049088"}],"facebook":[{"title":"Dolutegravir\u2013lamivudine as initial therapy in HIV-1 infected, ARV-naive patients, 48-week results of the PADDLE (Pilot Antiretroviral Design with Dolutegravir LamivudinE) study | Cahn | Journal of the International AIDS Society","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10155402962594697&id=296268839696","license":"public","citation_ids":[20107511],"posted_on":"2017-05-24T15:30:00+00:00","summary":"Using three different drugs in combination to control HIV replication has been the standard of care since the 90s. However, using more drugs elevates risk of tolerance buildup, toxicity, or treatment interruption due to the complexity of the regimen. Thus","author":{"name":"Journal of the International AIDS Society (JIAS)","url":"https:\/\/www.facebook.com\/296268839696","facebook_wall_name":"Journal of the International AIDS Society (JIAS)","image":"https:\/\/graph.facebook.com\/296268839696\/picture","id_on_source":"296268839696"}}]}}